Tumor necrosis factor-alpha -308G/A polymorphism and risk of hepatocellular carcinoma in hepatitis C virus-infected patients
- PMID: 22200181
- PMCID: PMC3777466
- DOI: 10.5732/cjc.011.10258
Tumor necrosis factor-alpha -308G/A polymorphism and risk of hepatocellular carcinoma in hepatitis C virus-infected patients
Abstract
Tumor necrosis factor-alpha (TNF-α) is an important cytokine in generating an immune response against infection with hepatitis C virus (HCV). The functions of TNF-α may be altered by single-nucleotide polymorphisms (SNPs) in its gene structure. We hypothesized that SNPs in TNF-α may be important in determining the outcome of an HCV infection. To test this hypothesis, we investigated the role of the polymorphism -308G/A, which is located in the promoter region of the TNF-α gene, in the progression of HCV infection in Egyptian patients using a quantitative real-time polymerase chain reaction (qRT-PCR). The distribution of this polymorphism and its impact on the serum level of TNF-α was compared between 90 HCV-infected patients [45 with HCV-induced cirrhosis and 45 with HCV-related hepatocellular carcinoma (HCC)] and 45 healthy Egyptian volunteers without any history of liver disease. Our results showed that at the TNF-α -308 position, the G/G allele was most common (78.5%) in the study population, with the G/A and A/A alleles occurring less frequently (13.3% and 8.1%, respectively). Frequencies of G/G, G/A, and A/A genotypes were 87%, 7%, and 6% in patients with liver cirrhosis and were 94%, 4%, and 2% in patients with HCC, respectively. Serum levels of TNF-α were significantly higher in HCV-infected patients than in healthy controls, indicating that the TNF-α -308 polymorphism does not influence the production of TNF-α. The serum level of TNF-α was positively correlated with HCV infection. Taken together, these findings suggest that the TNF-α -308 polymorphism may not be a host genetic factor associated with the severity of HCV infection, but may be an independent risk factor for HCC.
Figures
Similar articles
-
Impact of IL-27p28 (rs153109) and TNF-α (rs1800629) Genetic Polymorphisms on the Progression of HCV Infection in Egyptian Patients.Immunol Invest. 2019 Apr;48(3):255-267. doi: 10.1080/08820139.2018.1510958. Epub 2018 Sep 11. Immunol Invest. 2019. PMID: 30204505
-
Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.Cytokine. 2012 Oct;60(1):271-6. doi: 10.1016/j.cyto.2012.05.010. Epub 2012 Jun 6. Cytokine. 2012. PMID: 22682513
-
High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.Cytokine. 2013 Jun;62(3):421-5. doi: 10.1016/j.cyto.2013.03.024. Epub 2013 Apr 16. Cytokine. 2013. PMID: 23602201
-
Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma.World J Gastroenterol. 2013 Apr 28;19(16):2449-55. doi: 10.3748/wjg.v19.i16.2449. World J Gastroenterol. 2013. PMID: 23674845 Free PMC article. Review.
-
Host genetic factors associated with hepatocellular carcinoma in patients with hepatitis C virus infection: A systematic review.J Viral Hepat. 2018 May;25(5):442-456. doi: 10.1111/jvh.12871. Epub 2018 Mar 1. J Viral Hepat. 2018. PMID: 29397014 Free PMC article. Review.
Cited by
-
Tumor Necrosis Factor-α-308 G/A Polymorphisms and Risk of Hepatocellular Carcinoma: A Meta-Analysis.Hepat Mon. 2016 Apr 12;16(4):e33537. doi: 10.5812/hepatmon.33537. eCollection 2016 Apr. Hepat Mon. 2016. PMID: 27257425 Free PMC article. Review.
-
Tumor necrosis factor-alpha gene -308G > A polymorphism alters the risk of hepatocellular carcinoma in a Han Chinese population.Diagn Pathol. 2014 Nov 25;9:199. doi: 10.1186/s13000-014-0199-3. Diagn Pathol. 2014. PMID: 25420786 Free PMC article.
-
TNFA -308G>A and IL10 -1082A>G polymorphisms seem to be predictive biomarkers of chronic HCV infection.BMC Infect Dis. 2021 Nov 3;21(1):1133. doi: 10.1186/s12879-021-06835-9. BMC Infect Dis. 2021. PMID: 34732154 Free PMC article.
-
Association of cytokine gene polymorphisms with hepatitis C virus infection in a population from Rio de Janeiro, Brazil.Hepat Med. 2015 Nov 2;7:71-9. doi: 10.2147/HMER.S89447. eCollection 2015. Hepat Med. 2015. PMID: 26586969 Free PMC article.
-
The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages.Biomed Res Int. 2013;2013:187204. doi: 10.1155/2013/187204. Epub 2012 Dec 30. Biomed Res Int. 2013. PMID: 23533994 Free PMC article. Review.
References
-
- Shepard C, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5(9):558–567. - PubMed
-
- Dai C, Chuang W, Chang W, et al. Tumor necrosis factor alpha promoter polymorphism at position-308 predicts response to combination therapy in hepatitis C virus infection. J Infect Dis. 2006;193(1):98–101. - PubMed
-
- Lauer G, Walker B. Hepatitis C virus infection. N Engl J Med. 2001;345(1):41–52. - PubMed
-
- Donato F, Gelatti U, Limina R, et al. Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence. Oncogene. 2006;25(27):3756–3770. - PubMed
-
- Egyptian Ministry of Health Annual report. 2007 Available at http://www.mohp.gov.eg/Main.asp.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical